Cardiological evaluation in children and adolescents with Acute lymphoid leukemia - case analysis in a center of reference in pediatric oncology in Cascavel – PR
DOI:
https://doi.org/10.33448/rsd-v11i13.35586Keywords:
Acute lymphoid leukemia; ECG; Oncopediatric.Abstract
In the current scenario of Medicine, in which evidence-based studies have gained more and more space in the field of research, the chosen disease screening methods will be those that can be proven to bring more accurate diagnoses to patients. Within the aspect of Oncological Medicine, its lines of treatment and prognoses must have a sensitized and specific research, in order to avoid complications greater than the disorder itself. Such failures can be harmful to the patient, at different levels of health aspects. Thus, in this study, an individualized cardiological assessment was carried out through the ECG (electrocardiogram) in order to clarify the main cardiological changes caused by cancer treatment at the Hospital de Câncer de Cascavel - UOPECCAN in children and adolescents. are the main changes and their possible correlations among them that can lead to some harm to the patient undergoing cancer treatment.
References
Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., Flora, S. D., & Noonan, D. M. (2010). Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention. Journal of the National Cancer Institute, 102(1), 14-25.doi.org/10.1093/jnci/djp440
Brenner, M. K., & Pinkel, D. (1999). Cure of leukemia. Seminars in hematology, 6(4 Suppl 7), 73-83. https://pubmed.ncbi.nlm.nih.gov/10595756/
Camitta, B., Mahoney, D., Leventhal, B., Lauer, S. J., Shuster, J. J., Civin, S. A., & Strother, D. (1994). Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study. Journal of Clinical Oncology, 12(7), 1383-1389.doi.org/10.1200/JCO.1994.12.7.1383
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., Giacomi, G. D., & Cipolla, C. M. (2010). Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. Journal of the American College of Cardiology, 55(3), 213-220. doi:doi.org/10.1016/j.jacc.2009.03.095
Cardinale, D., Sandri, M. T., Martinoni, A., Tricca, A., Civelli, M., Lamantia, G., & Fiorentini, C. (2000). Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. Journal of the American College of Cardiology, 36(2), 517-522.doi.org/10.1016/s0735-1097(00)00748-8
Dolci, A., Dominici, R., Cardinale, D., Sandri, M. T., & Panteghini, M. (2008). Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. American journal of clinical pathology, 130(5), 688-695.doi.org/10.1309/AJCPB66LRIIVMQDR
Ewer, M. S., & Ewer, S. M. (2010). Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nature reviews. Cardiology, 7(10), 564-575.doi.org/10.1038/nrcardio.2010.121
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010). Radiation dose-volume effects in the heart. International journal of radiation oncology, biology, physics, 73(3 Suppl), S77-85.doi.org/10.1016/j.ijrobp.2009.04.093
Geiger, S., Lange, V., Suhl, P., Heinemann, V., & Stemmler, H.-J. (2010). Anticancer therapy induced cardiotoxicity: review of the literature. Anti-cancer drugs, 21(6), 578-590.doi.org/0.1097/CAD.0b013e3283394624
Gurney, J. G., Severson, R. K., Davis, S., & Robison, L. L. (1995). Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer, 75(8), 2186-2195.doi.org/10.1002/1097-0142(19950415)75:8<2186::aid-cncr2820750825>3.0.co;2-f
Kalil Filho, R., Hajjar, L., Bacal, F., Hoff, P., Diz, M. d., & Galas, F. (2011). I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia. Arquivos Brasileiros de Cardiologia, 96(2 Suppl 1), 1-52.doi.org/10.1590/S0066-782X2011000700001
Khakoo, A. Y., & Yeh, E. T. (2008). Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nature clinical practice. Oncology, 5(11), 655-667.doi.org/10.1038/ncponc1225
Kilickap, S., Barista, I., Akgul, E., Aytemir, K., Aksoy, S., & Tekuzman, G. (2007). Early and late arrhythmogenic effects of doxorubicin. Southern medical journal, 100(3), 262-265.doi.org/10.1097/01.smj.0000257382.89910.fe
Marina, N. (1997). Long-term survivors of childhood cancer. The medical consequences of cure. Pediatric clinics of North America, 44(4), 1021-1042.doi.org/10.1016/s0031-3955(05)70543-5
Miliosse, B. d. (2018). Relação Entre Alterações Eletrocardiográficas E O Desenvolvimento De Cardiotoxicidade Após O Uso De Agentes Quimioterápicos. Niteroi: Universidade Federal Fluminense. https://app.uff.br/riuff/handle/1/7973?locale-attribute=en
Ministério da Saúde. (2012). Resolução Nº 466, de 12 de Dezembro de 2012. Acesso em 22 de Outubro de 2021, Ministério da Saúde: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html
Morettin, P. A., & Bussab, W. d. (1987). Estatística Básica. São Paulo: Atual.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metolodogia da Pesquisa Científica. Santa Maria: UFSM.
Sengupta, P. P., Northfelt, D. W., Gentile, F., Zamorano, J. L., & Khandheria, B. K. (2008). Trastuzumab-induced cardiotoxicity: heart failure at the crossroads. Mayo Clinic proceedings, 83(2), 197-203.doi.org/10.4065/83.2.197
Silveira, A. C., Coutinho, L. N., & Correa, G. T. (2022). Oral manifestations in pediatric patients with Acute Lymphoid Leukemia. Research, Society and Development, 11(7), 1-11.doi.org/10.33448/rsd-v11i7.30119
Singal, P. K., & Iliskovic, N. (1998). Doxorubicin-induced cardiomyopathy. The New England journal of medicine, 339(13), 900-905.doi.org/10.1056/NEJM199809243391307
Steinherz, L. J., Graham, T., Hurwitz, R., Sondheimer, H. M., Schwartz, R. G., Shaffer, E. M., & Williams, R. (1992). Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics, 88(5 pt 1), 942-949. https://pubmed.ncbi.nlm.nih.gov/1579408/
Waligóra, M., Tyrka, A., Miszalski-Jamka, T., Urbańczyk-Zawadzka, M., Podolec, P., & Kopeć, G. (2018). Right atrium enlargement predicts clinically significant supraventricular arrhythmia in patients with pulmonary arterial hypertension. Heart & lung : the journal of critical care, 47(3), 237-242.doi.org/10.1016/j.hrtlng.2018.01.004
Yeh, E. T., Tong, A. T., Lenihan, D. J., Yusuf, S. W., Swafford, J., Champion, C., & Ewer, M. S. (2004). Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation, 109(25), 3122-3131.doi.org/10.1161/01.CIR.0000133187.74800.B9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Leticia de Oliveira Mercante; Carmem Maria Costa Mendonça Fiori
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
